Advanced in Primary Lymphoma of the Brain

Dr. Robin M. Joyce

Hematology Oncology | Hematology | Oncology
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
330 Brookline Ave, 
Boston, MA 
Accepting New Patients
Advanced in Primary Lymphoma of the Brain
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
330 Brookline Ave, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robin Joyce is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Joyce is rated as an Advanced provider by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Joyce is currently accepting new patients.

Her clinical research consists of co-authoring 53 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MA
Hospital Affiliations
Beth Israel Deaconess Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO

Locations

HARVARD MEDICAL FACULTY PHYS AT BETH ISRAEL DEACONESS MED CTR INC
330 Brookline Ave, Boston, MA 02215

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I/II Study of Pyrimethamine, a STAT3 Inhibitor, for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Phase I/II Study of Pyrimethamine, a STAT3 Inhibitor, for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment Status: Completed
Publish Date: February 22, 2023
Intervention Type: Drug
Study Drug: Pyrimethamine
Study Phase: Phase 1/Phase 2
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1, Open-label, Dose-escalation Study of SGN-CD19B in Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
A Phase 1, Open-label, Dose-escalation Study of SGN-CD19B in Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
Enrollment Status: Terminated
Publish Date: August 13, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

53 Total Publications

High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.
Journal: Transfusion
Published: January 08, 2024
Similar Doctors
Distinguished in Primary Lymphoma of the Brain
Dr. Eric D. Jacobsen
Hematology Oncology | Hematology | Oncology
Distinguished in Primary Lymphoma of the Brain
Dr. Eric D. Jacobsen
Hematology Oncology | Hematology | Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Eric Jacobsen is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Jacobsen is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Langerhans Cell Histiocytosis, Multicentric Reticulohistiocytosis, Histiocytosis, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jacobsen is currently accepting new patients.

Distinguished in Primary Lymphoma of the Brain
Dr. Lakshmi S. Nayak
Oncology | Neurology
Distinguished in Primary Lymphoma of the Brain
Dr. Lakshmi S. Nayak
Oncology | Neurology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lakshmi Nayak is an Oncologist and a Neurologist in Boston, Massachusetts. Dr. Nayak is rated as an Elite provider by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Astrocytoma, Glioma, Glioblastoma, and Brain Tumor. Dr. Nayak is currently accepting new patients.

Distinguished in Primary Lymphoma of the Brain
Dr. Ephraim P. Hochberg
Oncology | Hematology
Distinguished in Primary Lymphoma of the Brain
Dr. Ephraim P. Hochberg
Oncology | Hematology

The General Hospital Corporation

55 Fruit St, 
Boston, MA 
 (2.5 miles away)
617-726-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ephraim Hochberg is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Hochberg is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Hochberg is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Joyce's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 12 Advanced Conditions
    View All 38 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile